Family First today announced that if elected to the Senate, its representatives will move urgently to establish a Senate inquiry into the safety of the abortion pill, mifepristone.
This follows alarming new research from the Ethics and Public Policy Center revealing that one in ten women who take the abortion pill suffer serious, sometimes life-threatening complications—including sepsis, haemorrhaging, and infection. The study analysed 865,727 prescribed mifepristone abortions between 2017 and 2023, making it the largest real-world study of the abortion pill ever conducted.
The real-world harm rate of 10.93 per cent is at least 22 times worse than what abortion advocates and manufacturers have long claimed.
Family First said Australian women deserve better than dangerous chemicals falsely marketed as "safe and effective."
There are real questions about the safety of the abortion pill. Australian regulators must not turn a blind eye to growing evidence of harm. If elected, Family First Senators will immediately move for a Senate inquiry into the safety of mifepristone and the loosening of protections under Australian law.
Women have a right to full disclosure about the risks, not just the propaganda of the abortion industry.
Family First stands unashamedly for the sanctity of life and the dignity of every woman and child. If elected, its Senators will fight for stronger protections for vulnerable women and to expose the harms of the abortion industry's push for chemical abortions.
The inquiry will examine current Australian approval processes, adverse event reporting, and whether the Therapeutic Goods Administration (TGA) has sufficiently safeguarded women's health given the disturbing real-world data emerging from overseas.
Australia must not ignore these warnings. Family First will fight to put women's health and unborn children's lives first.
Family First's Senate team includes Katie Lush and Karen Fuller (Queensland), Lyle Shelton and Roseanne Masters (New South Wales), Bernie Finn and Jane Foreman (Victoria), and Christopher Brohier and Deepa Mathew (South Australia).
